Cellular genes as targets for anti-HIV Therapies
Cellular genes as targets for anti-HIV Therapies
批准号:
6545092
负责人:
H GOLDING
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS vaccines CD4 molecule CD8 molecule HIV infections SCID mouse T lymphocyte apoptosis cell population study clinical research cytokine cytokine receptors gene expression host organism interaction human immunodeficiency virus 1 human tissue immunocytochemistry immunogenetics immunoglobulin G immunologic substance development /preparation immunoregulation laboratory rabbit protein structure function thymus disorder vaccine development viral vaccines virus infection mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary: (1) Goals of project:
- To identify cellular genes required for optimal HIV-1 infection, or involved in HIV-1 pathogenesis.
- To study the mechanism by which intrathymic HIV-1 infection affects the development of different T cell subsets.
- To understand how HIV-1 infection leads to high levels of programmed cell cell in both CD4 and CD8 cells.
- To apply the knowledge gained towards development of anti-viral therapy which target both viral and cellular genes.
- To study in situ expression of chemokines and cytokines in normal and HIV-1-infected human thymic tissues.
(2) Experimental approach:
- Scid/Hu mice were infeected intrathymically with primary isolate of HIV. Frozen sections were stained by immunohistochemistry with antibodies against HIV-1 p24, HIV-1 coreceptors, and against the CXCR4 ligand SDF1.
- Rabbit Igs specific for the CXCR4 and CCR5 extracellular domains were produced and tested for their ability to stain primary human cells and to block viral fusion and infection.
- Study coreceptor expression and function on human thymocyte subpoulations and correlate coreceptor expression with susceptibility to infection with different hiv strains.
- Develop imuunohistochemisry staining of thymic tissues to determine the sites and cellular origin of various chemokines and cytokines that may affect HIV infections and potential thymic regeneration in infected children on HAART.
(3) Major Findings:
- Studies with human thymocyte subpopulations from infants, revealed very high expression of the CXCR4 coreceptor on immature thymocytes, including CD34+ intrathymic precursors. Thymocytes responded to the chemokine SDF1 by chemotaxis and Ca++ mobilization. They fused readily with T-tropic HIV envelopes and the fusion was blocked by our rabbit anti-CXCR4 IgG. In addition, we have evidence that another chemokine receptor (I-309R) is expressed in human thymocytes and provides co-recptor function for infection with T-tropic and M-trpic strains. These data explain the exquisite sensitivity of neonatal thymuses to infection with T-tropic HIV strains that often result in sever thymic depletion.
- IHC staining demonstrated that SDF-1 is highly expressed in normal thymus in the stromal cells surrounding Hassels' bodies in the medulla. SDF1/CXCR4 interactions play a pivotal role in thymopoiesis, i.e., removal of apoptotic thymocytes by thymic dendritic cells. In HIV-1 infected thymuses, the Hassels' bodies were significantly enlarged and constituted > 50% of the medulla. The staining with anti-SDF1 mAb was eventually reduced. These changes may represent the pathologic process leading to eventual destruction of the thymic architecture. Manuscript submitted
- New findings suggest that, in addition to the chemokine receptors CXCR4 and CCR5, infection of human thymocytes can occur via the CCR8 chemokine receptor. Such infection can be blocked by the CCR8 ligand I309. This is the first evidence for in vivo usage of chemokine receptor other than CCR5 and CXCR4. Manuscript published.
- Preliminary data suggest that IL7 is produced by epithelial cells in the thymus. Apoptosis inducing regiments (i.e., in vivo treatment with corticosteroids) upregulate IL7 and re-start thymopoiesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV-1 MEDIATED MEMBRANE FUSION AS TARGET OF ANTI-VIRAL THERAPY
-
批准号:2568922
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:5200713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CHARACTERIZATION OF T CELL RECEPTOR GENES IN ALLOREACTIVE CLONES
-
批准号:3939366
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:
PRODUCTION OF ANTI-HIV-1 VACCINE
-
批准号:3748147
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
GENERATION OF AUTOANTIBODIES IN HIV-1 VACCINE GROUPS
-
批准号:3770316
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3770315
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF T-INDEPENDENT HIV 1 VACCINE
-
批准号:3811246
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
STUDIES OF HIV-1 ENV-MEDIATED MEMBRANE FUSION AND SYNCYTIA FORMATION
-
批准号:3804800
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF PEPTIDE-BASED, T CELL INDEPENDENT HIV-1 VACCINE
-
批准号:3804795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF SAFETY OF MONOCLONAL ANTIBODIES AGAINST HIV ENVELOPE AND ITS CELLUL
-
批准号:6293720
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV1 INFECTION AS TARGETS FOR ANTIVIRAL THERAPY
-
批准号:6161239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of vaccinia IgG (VIG) in the protection of mi
-
批准号:6545148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral
-
批准号:6678831
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
PRODUCTION OF ANTI-HIV-1 THERAPEUTIC VACCINE
-
批准号:2568923
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
CELLULAR GENES REQUIRED FOR HIV-1 INFECTION AS TARGETS FOR THERAPY
-
批准号:3748144
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
EVALUATION OF NEW CARRIERS AND ADJUVANTS FOR HIV-1 VACCINES.
-
批准号:6293722
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
HIV-1 mediated membrane fusion as target for anti-viral therapy
-
批准号:6433505
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of new carriers and adjuvants for HIV-1 vaccines.
-
批准号:6433506
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
Evaluation of new carriers/adjuvants for HIV-1 vaccines
-
批准号:6545100
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
ANALYSIS OF HIV-1 CELL ENTRY USING CHEMICALLY INDUCED T CELL MUTANTS
-
批准号:3811244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H GOLDING
-
依托单位:--
海外基金